Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Dr. Reddy's Laboratories Limited (NSE: DRREDDY), ISIN INE089A01031 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
DRREDDY last traded at ₹1211.20 (+0.02%), with a 52-week range of ₹1080.05 to ₹1414.40 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 26.64%, FIIs 32.07%, DIIs 31.74%, mutual funds 13.16%.
EquiSense Score (ECS): 39/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.